A research team is examining the potential link between COVID-19 and increased risk of Parkinson's disease, as well as measures to get ahead of the curve
ImmunoRankoffers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins